Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 20.40
+0.10 (0.49%)
Nov 19, 2025, 3:11 PM CET
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.49 billion as of November 19, 2025. Its market cap has increased by 7.62% in one year.
Market Cap
1.49B
Enterprise Value
1.81B
Revenue
918.75M
Ranking
n/a
PE Ratio
17.35
Stock Price
€20.40
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.49B, an increase of 376.57%. That is a compound annual growth rate of 9.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 1.49B | 21.75% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | 1.38B | -1.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.72B |
| UCB SA | 43.11B |
| Financière de Tubize | 8.95B |
| Ion Beam Applications | 305.54M |
| Onward Medical | 180.75M |
| Hyloris Pharmaceuticals | 159.04M |
| Nyxoah | 155.92M |
| Sequana Medical NV | 38.18M |